SARASOTA, Fla., April 22, 2014 (GLOBE NEWSWIRE) -- Caribbean International Holdings (Pink Sheets:CIHN) through its subsidiary, Regenerative BioScience, will add brain injuries including Chronic traumatic encephalopathy (CTE) as an additional area of focus to see how stem cells may help to improve the lives of those dealing with these difficult injuries.

Steven Swank, Chairman and CEO of Caribbean International Holdings, stated "I have met personally with ex-professional athletes that are suffering from CTE and have heard first-hand the heart-wrenching stories of how this affects their daily lives. Through our medical experts and the addition of sports experts, players, and trainers to our Advisory Board that we are currently working on, we hope to find ways to help. We understand even the most minor progress can greatly improve how those suffering from these traumatic injuries can improve their quality of life."

Should anyone suffering from CTE be interested in finding out more information, please contact us. We will also continue progressing with our research in additional areas including; but not limited to, Congestive Heart Failure, Cardiomyopathy, Coronary Artery Disease, Angina Pectoris, Ischemic Heart Disease, Non-Ischemic Heart Disease, COPD, and Pulmonary Fibrosis that is already delivering promising results.

FORWARD-LOOKING STATEMENT

This report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation.